Survival rate surpasses historical outcomes in a small phase I study ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

All types of brain cancers collectively have a five-year survival rate of just 33%, according to the National Cancer ...

Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...

According to the National Brain Tumor Society, approximately 1.3 million Americans are living with a brain tumor. The ...

A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...

SALT LAKE CITY — The five-year survival rate for all cancers combined has reached a historic 70%, according to the latest American Cancer Society Cancer Statistics 2026 report, based on all people ...

Oligodendroglioma is a rare type of brain tumor. It’s in a category of brain and spinal cord tumors called gliomas. These are brain or spinal cord tumors that come from abnormal glial cells, the ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...